Cargando…
Hydration-Induced Phase Separation in Amphiphilic Polymer Matrices and its Influence on Voclosporin Release
Voclosporin is a highly potent, new cyclosporine-A derivative that is currently in Phase 3 clinical trials in the USA as a potential treatment for inflammatory diseases of the eye. Voclosporin represents a number of very sparingly soluble drugs that are difficult to administer. We therefore selected...
Autores principales: | Khan, I. John, Murthy, N. Sanjeeva, Kohn, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030927/ https://www.ncbi.nlm.nih.gov/pubmed/24955746 http://dx.doi.org/10.3390/jfb3040745 |
Ejemplares similares
-
Voclosporin: First Approval
por: Heo, Young-A
Publicado: (2021) -
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin
por: Abdel-Kahaar, Emaad, et al.
Publicado: (2023) -
Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013) -
Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
por: Roesel, Martin, et al.
Publicado: (2011) -
Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA
por: Auguste, Bourne, et al.
Publicado: (2021)